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A tetrahedral intermediate is the prominent feature of the generally accepted mechanism for aspartate transcarbamoylase. We have synthesized 
N-pyrophosphoryl-L-aspartate asa charged analogue of the postulated intermediate. Surprisingly, its affinity for the enzyme from Escherichiu coli 
was substantially lower than that of the previously known inhibitor phosphonoacetyl-L-aspartate which contained a trigonal carbonyl group. Simi- 
lar results were obtained with the corresponding mercaptosuccinate d rivatives. We also tested a number of new pyrophosphate analogues as inhibi- 
tors. Our results cast doubt on some aspects of the current model for the mechanism of this enzyme. 
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1. INTRODUCTION 
ATCase (EC 2.1.3.2) has aroused considerable in- 
terest both as a model regulatory enzyme [l] and as a 
potential target for chemotherapy [2]. In a previous at- 
tempt to develop tight-binding inhibitors, we probed 
the active site of the enzyme from Escherichia coli with 
various substrate analogues [3]. The results suggested 
that stabilization of a negatively charged transition 
state might be an important aspect of the catalytic 
mechanism. We have now tested the hypothesis by syn- 
thesizing a putative transition-state analogue. The bin- 
ding of this inhibitor and that of other phosphorus- 
containing compounds provide additional insight into 
the structure and function of this enzyme. 
2. MATERIALS AND METHODS 
ATCase was isolated from E. coli and the subunits were separated 
by well-established methods [4,5]. Enzyme activity was measured 
following incorporation of 14C label from carbamoyl phosphate as 
previously described ]3] except that sodium carbonate (100 ~1 of 0.1 
M) was added to each vial instead of crushed dry ice to complete the 
removal of 14COr. The pattern of inhibition was determined by 
analyzing the data with double reciprocal plots [6] and the inhibition 
constants were estimated according to Dixon [7]. The K, values are 
average values of at least two separate determinations using four dif- 
ferent concentrations of both carbamoyl phosphate and inhibitor. 
All starting materials were used without further purification and 
were obtained from Sigma Chemical, except for phosphorus ox- 
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ychloride and triethylamine (BDH Chemicals), D,L-mercaptosuccinic 
acid and thionyl chloride (Aldrich Chemicals), acetonitrile (Fisher 
Scientific), and 3-phosphonopropionic acid (Fluka AG). Perox- 
ydiphosphonate was a gift from Prof. N.J. Leonard, University of 
Illinois at Urbana-Champaign, USA. 
The synthesis and characterization of dichloromethylene 
diphosphonate, carbonyl diphosphonate and hypophosphate have 
been reported elsewhere [g-lo]. N-Ethylphosphonoformamide was 
prepared analogously to what has been described for other carbamoyl 
phophonic acids [ 111. 
N-pyrophosphoryl-L-aspartate was prepared by the reaction of 
pyrophosphoryl tetrachloride with L-aspartate under conditions 
previously used for the synthesis of N-phosphoryl-L-aspartate [12]. 
The mercaptosuccinate d rivatives were synthesized by treatment of 
the thiol with the acid chloride in acetonitrile in the presence of 
triethylamine. The products were isolated by column chromatography 
or fractional precipitation [12]. The methods used to ascertain purity 
included “P-NMR and quantitative analysis before and after 
hydrolysis. The analytical procedures covered the determination of 
aspartate [3], phosphate and pyrophosphate [13], and free thiol and 
thiol ester content [14]. Details of the synthesis and characterization 
of these new inhibitors will be published separately (Laing, N. and 
Chan, W.W.-C., in preparation). 
3. RESULTS AND DISCUSSION 
The reaction catalyzed by ATCase is generally con- 
sidered to proceed via a nucleophilic attack by the free 
amino group of L-aspartate on the carbon of car- 
bamoyl phosphate [15,16] (fig. 1). The ensuing 
tetrahedral intermediate may either accept a proton or 
remain as a fully charged oxyanion. Since previous 
results appeared to favor the latter possibility [3], we 
deemed it worthwhile to synthesize N-pyrophosphoryl- 
L-aspartate (fig. 1) as a potential transition-state 
analogue. As in our earlier study [3], the effects of 
various compounds were tested on the catalytic subunit 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/90/%3.50 0 1990 Federation of European Biochemical Societies 206 
Volume 260, number 2 FEBS LETTERS January 1990 
cl OQ 
“0 QO 
-* ,- 
c 
HO-LO-6 - NH-Ai-C”*-C 
,O” 
;J A b 
Fig. 1. Schematic representation of the active site of ATCase. The top 
section illustrates the generally accepted mechanism of the reaction. 
The lower section shows the structure of the putative transition-state 
analogue aligned in the same manner as the substrates. 
of the enzyme from E. cofi, all of which inhibited the 
enzyme competitively with respect to carbamoyl 
phosphate. 
Although N-pyrophosphoryl-L-aspartate inhibits 
ATCase, its affinity is much weaker than expected (see 
2 in table 1). In fact, it binds to the enzyme approx- 
imately 9-fold less tightly than the bisubstrate analogue 
PALA (l), discovered many years ago by Collins and 
Stark (171. This surprising result indicates that binding 
occurs preferentially with an uncharged trigonal car- 
bony1 group in this critical position of the inhibitor. 
Nevertheless, the pyrophosphoryl group must interact 
with the enzyme favorably overall since the correspon- 
ding phosphoryl derivative (3) has a 200-fold lower af- 
finity. 
In order to confirm these observations, we also syn- 
thesized the sulfur analogues of the above aspartate 
derivatives. The behavior of this series of compounds is 
qualitatively similar to that of their nitrogen-containing 
counterparts. Thus S-phosphonoacetyl-mercaptosuc- 
cinate (4) is a significantly more powerful inhibitor than 
4pyrophosphoryl-mercaptosuccinate (5), which is in 
turn stronger than the S-phosphoryl derivative (6). The 
differences in affinity between these inhibitors are, 
however, much smaller than those in the aspartate 
series, suggesting that the NH group may have a special 
role in promoting tight binding of adjacent functional 
groups. It is also clear that the NH group makes a large 
contribution towards the strength of binding. Thus the 
affinity of PALA for ATCase is at least lOO-fold higher 
than that of its sulfur analogue (even allowing for the 
possibility that only the L-isomer of the latter may be 
active). It is interesting that the oxygen analogue (7) 
synthesized by Farrington et al. [18] has an affinity 
similar to that of the sulfur derivative. This result may 
mean that the hydrogen bonding capability of the NH 
group is responsible for the stronger interaction of the 
aspartate derivatives. 
The above observations eemed at first to be incom- 
patible with the previous finding of an anion-binding 
site at the reaction centre. We therefore proceeded to in- 
Table 1 
Inhibition of ATCase bv dicarboxvlate derivatives 
Inhibitor (R = -CH-COz-) Ki 
CHz-COz- (IIM) 
-0 0 
II II 
-0-P-CHz-C-NH-R (L) 
II 
0 
0.027 [17] 
-0 -0 
I I 
-O-P-O-P-NH-R(L) 
II II 
0 0 
0.24 
-0 
I 
-O-P-NH-R (L) 
II 
0 
50 [31 
-0 0 
I II 
-0-P-CHz-C-S-R (L) 5.5 
II 
0 
-0 -0 
I I 
-O-P-O-P-S-R (DL) 17 
II II 
0 0 
-0 
I 
-O-P-S-R (DL) 
II 
0 
125 
-0 0 
I II 
-0-P-CHz-C-O-R (L) 
II 
2.0 [18] 
0 
vestigate more fully the binding of phosphate and 
phosphonate derivatives containing additional negative 
charges. Pyrophosphate (9, table 2) may be regarded as 
the classical example of this type of compound and it 
has already been shown to be a good inhibitor. We find 
that the distance between the phosphate groups has an 
important influence on the affinity of these derivatives. 
Thus hypophosphate (8) binds significantly tighter than 
pyrophosphate, whereas peroxydiphosphonate (10) is a 
much weaker inhibitor. A similar effect has also been 
demonstrated for phosphonoformate (11) and phos- 
phonoacetate (12) [3]. A further increase in distance 
between the charged groups (13) led to an even greater 
decrease in affinity. It is noteworthy that hypophos- 
phate and phosphonoformate have virtually identical 
inhibition constants for ATCase. Thus there seems to 
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Table 2 
Inhibition of ATCase by pyrophosphate analogues 
Inhibitor Ki 
01M) 
8 ‘-OsP-POpH- 
9 ‘-OpP-0-POSH- 
10 2-OpP-O-O-P0rH- 
ll~-o~P-c02- 
12 2-03P-CH2-C0,- 
13 ‘-O~P-CH~-CH~-COZ- 
14 2-03P-CH2-P03H- 
15 2-03P-NH-P0,H- 
16 2 -03P - CC12 - PO3H - 
17 *-OjP-C-POSH- 
II 
0 
20 
51 [21,3] 
175 
22 131 
150 [21,3] 
7500 
37 t31 
71 
32 
3.5 
18 2-OsP-C-NH-CH2-CH3 
II 
0 
2ooo 
be no preference for a particular configuration for this 
group as long as its charge and location are appropriate. 
It had also been observed previously [3] that very lit- 
tle change in affinity occurred when the oxygen bridge 
of pyrophosphate was replaced by a methylene 
equivalent (14). Our results here also show that binding 
is not greatly affected when an imido (15) or a 
dichloromethylene group (16) occupies this bridge posi- 
tion. However, substitution by a carbonyl group at this 
site (17) leads to a highly potent inhibitor. The large in- 
crease in affinity in this case is probably due to the 
orientation of the phosphonate groups brought upon by 
the trigonal carbon atom rather than the interaction of 
the carbonyl group itself. This interpretation is sup- 
ported by the finding that replacement of one phos- 
phonate group by an ethylamido moiety (18) produced 
a drastic loss of affinity. 
The evidence presented above supports the previous 
contention [3] that there is an anion-binding site in 
ATCase in the vicinity of the phosphate-binding region. 
However, it now appears that this site is not involved in 
stabilizing a negatively charged tetrahedral transition 
state as has been postulated. It is perhaps important to 
note that phosphoroamidates are potent inhibitors of 
some proteases whose reactions are believed to proceed 
via similar tetrahedral intermediates [ 191. Thus it seems 
unlikely that the failure of N-pyrophosphoryl aspartate 
to act as a transition-state anald ue in this work is due 
to the different properties ( .g. 
I 
bondlengths) of 
phosphorus analogues. It shoul also be pointed out 
that in a previous study of ATCase [20], a neutral 
tetrahedral analogue incorporating a hydroxyl function 
was found to be a poor inhibitor compared to its 
trigonal counterpart (the corresponding ketone). We 
are therefore forced to consider the possibility that the 
mechanism of ATCase may not involve formation of a 
tetrahedral intermediate. A viable alternative would be 
for the reaction to proceed in a concerted manner in 
which nucleophilic attack by the amino group and 
departure of phosphate occur simultaneously. In such a 
mechanism, the anion-binding site may have the func- 
tion of facilitating the cleavage of the phosphate group. 
It would seem worthwhile to design experiments for 
testing such a hypothesis. 
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